These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 946133)

  • 1. [Recurrence after thyreostatic treatment of diffuse toxic goiter in relation to iodine intake].
    Lumholtz IB; Poulsen DL; Siersbaek-Nielsen K; Friis T; Rogowski P; Kirkegaard C; Hansen JM
    Ugeskr Laeger; 1976 Jan; 138(2):83-5. PubMed ID: 946133
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recurrence rate following thyrostatic therapy of patients with hyperthyroidism and diffuse goiter (Graves' disease). Relation to the concentration of inorganic iodine in the plasma].
    Hansen PE
    Ugeskr Laeger; 1983 Mar; 145(13):980-2. PubMed ID: 6190284
    [No Abstract]   [Full Text] [Related]  

  • 3. Late recurrence of Graves' disease.
    Lewis NP
    Br J Clin Pract; 1989 Feb; 43(2):82. PubMed ID: 2803906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with carbimazole in the drug treatment of the hyperthyroidism of Graves' diseases in Nigerians.
    Modebe O
    East Afr Med J; 1992 Mar; 69(3):153-6. PubMed ID: 1505405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recurrence of Graves-Basedow disease: the influence of treatment schedule].
    Goñi Iriarte MJ; Forga Llenas L; Iriarte Beroiz A; Apiñániz EA; Rodríguez Erdozain R; Menéndez Torre E
    Med Clin (Barc); 1995 Jan; 104(1):11-4. PubMed ID: 7877347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
    El Refaei SM; Shawkat W
    Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complex treatment of toxic goiter].
    Kal'chenko II; Nechiporenko FP
    Sov Med; 1973 Oct; 36(10):99-102. PubMed ID: 4133131
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum immunoglobulin levels in thyroid disease.
    Glynne A; Thomson JA
    Clin Exp Immunol; 1972 Sep; 12(1):71-8. PubMed ID: 4628405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of Graves-Basedow disease].
    Angel M
    Med Clin (Barc); 1988 May; 90(18):748-54. PubMed ID: 2902259
    [No Abstract]   [Full Text] [Related]  

  • 11. Long term low dose carbimazole as a treatment for thyrotoxicosis. A report of ten cases with a review of the literature.
    Morgan GJ; Mayberry JF; Swithinbank JM
    Br J Clin Pract; 1984 Jun; 38(6):226-8. PubMed ID: 6547616
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U; Gerber H; Peter HJ
    Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of dose selection on absorbed dose profiles in radioiodine treatment of diffuse toxic goiters in patients receiving or not receiving carbimazole.
    Clerc J; Izembart M; Dagousset F; Jaïs JP; Heshmati HM; Chevalier A; Léger AF; Barritault L
    J Nucl Med; 1993 Mar; 34(3):387-93. PubMed ID: 8441028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thyroid diseases in sub-Saharan Africa].
    Sidibé el H
    Sante; 2007; 17(1):33-9. PubMed ID: 17897900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contemporary treatment of diffuse toxic goiter].
    Spesivtseva VG; Liashko KIa
    Sov Med; 1970; 33(8):103-11. PubMed ID: 4099132
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of patients with diffuse toxic goitre in Ireland, a country with low iodine intake.
    Smith A; McKenna TJ
    Ir J Med Sci; 1992 Oct; 161(10):597-9. PubMed ID: 1478841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radioisotope methods of control of the effectiveness of treatment of diffuse toxic goiter with mercazolyl].
    Egorenkov AN
    Med Radiol (Mosk); 1976; 21(9):47-53. PubMed ID: 1036752
    [No Abstract]   [Full Text] [Related]  

  • 19. Early treatment with low fixed dose (5 mCi) radioiodine therapy is effective in Indian subjects with Graves' disease.
    Sanyal D; Mukhhopadhyay P; Pandit K; Chatterjee J; Raychaudhuri M; Mukherjee S; Chowdhury S
    J Indian Med Assoc; 2008 Jun; 106(6):360-1, 372. PubMed ID: 18839646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of outcome in Graves' disease after carbimazole treatment.
    Weetman AP; Ratanachaiyavong S; Middleton GW; Love W; John R; Owen GM; Darke C; Lazarus JH; Hall R; McGregor AM
    Q J Med; 1986 Apr; 59(228):409-19. PubMed ID: 2875484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.